You just read:

Boston Biomedical Presents Data for Investigational Cancer Stemness Inhibitor Napabucasin in Metastatic Colorectal and Pancreatic Cancer at ESMO GI 2017

News provided by

Boston Biomedical, Inc.

Jun 30, 2017, 08:00 ET